These results are in line with findings from Osei-Hyiaman and colleagues (Osei-Hyiaman et al., 2008), demonstrating that LCB1 cKO mice are resistant to obesity-induced hyperleptinemia. Here, SPTLC1 is linked to obesity disorder.